SCHEMBL29180242

SCHEMBL29180242

O=c1oc(-c2ccc(O)cc2)cc2c(Cl)ccc(O)c12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 1/20 0.57
▸ CYP3A4 P08684 4/20 0.48
▸ HPGD P15428 4/20 0.48
▸ KMT2A Q03164 4/20 0.48
▸ MAPT P10636 4/20 0.48
▸ MAPK1 P28482 3/20 0.48
▸ AR P10275 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ RAF1 P04049 1/20 0.48
▸ TERT O14746 1/20 0.47
▸ ALPL P05186 2/20 0.46
▸ ALPI P09923 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ KDM4E B2RXH2 4/20 0.44
▸ IP6K2 Q9UHH9 4/20 0.44
▸ NPC1 O15118 4/20 0.44
▸ TDP1 Q9NUW8 4/20 0.44
▸ ESR1 P03372 3/20 0.44
▸ ESR2 Q92731 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29180248 0.81 PTGES (0.47) PTGESCYP3A4HPGDKMT2AMAPT
SCHEMBL28548525 0.78 PTGES (0.51) PTGESCYP3A4HPGDKMT2AMAPT
SCHEMBL28551500 0.78 TERT (0.51) PTGESCYP3A4HPGDKMT2AMAPT
SCHEMBL29180249 0.72 PTGES (0.43) PTGESCYP3A4HPGDKMT2AMAPT
SCHEMBL23299597 0.69 CDK5 (0.72) CYP3A4HPGDKMT2AMAPTMAPK1
SCHEMBL3925355 0.69 NPC1 (0.55) CYP3A4HPGDKMT2AMAPTMAPK1
SCHEMBL29180243 0.69 PTGES (0.39) PTGESCYP3A4HPGDKMT2AMAPT
SCHEMBL20953928 0.67 SHBG (0.59) PTGESCYP3A4HPGDMAPTMAPK1
SCHEMBL28548041 0.67 ESR1 (0.57) PTGESCYP3A4HPGDKMT2AMAPT
SCHEMBL14296721 0.66 MEN1 (0.48) PTGESCYP3A4HPGDKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112601743-B Flavone compounds for the treatment and prevention of hepatitis b virus diseases 豪夫迈·罗氏有限公司 2023-12-19 — — CN disclosed
Send feedback